1. Home
  2. HALO vs FRT Comparison

HALO vs FRT Comparison

Compare HALO & FRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • FRT
  • Stock Information
  • Founded
  • HALO 1998
  • FRT 1962
  • Country
  • HALO United States
  • FRT United States
  • Employees
  • HALO N/A
  • FRT N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • FRT Real Estate Investment Trusts
  • Sector
  • HALO Health Care
  • FRT Real Estate
  • Exchange
  • HALO Nasdaq
  • FRT Nasdaq
  • Market Cap
  • HALO 7.4B
  • FRT 8.2B
  • IPO Year
  • HALO N/A
  • FRT N/A
  • Fundamental
  • Price
  • HALO $54.54
  • FRT $92.53
  • Analyst Decision
  • HALO Buy
  • FRT Buy
  • Analyst Count
  • HALO 9
  • FRT 12
  • Target Price
  • HALO $63.56
  • FRT $115.42
  • AVG Volume (30 Days)
  • HALO 3.3M
  • FRT 717.0K
  • Earning Date
  • HALO 05-06-2025
  • FRT 05-08-2025
  • Dividend Yield
  • HALO N/A
  • FRT 4.75%
  • EPS Growth
  • HALO 55.40
  • FRT 23.89
  • EPS
  • HALO 3.76
  • FRT 3.47
  • Revenue
  • HALO $1,084,306,000.00
  • FRT $1,223,588,000.00
  • Revenue This Year
  • HALO $25.77
  • FRT $5.01
  • Revenue Next Year
  • HALO $18.01
  • FRT $5.77
  • P/E Ratio
  • HALO $14.51
  • FRT $26.63
  • Revenue Growth
  • HALO 25.64
  • FRT 6.05
  • 52 Week Low
  • HALO $42.01
  • FRT $80.65
  • 52 Week High
  • HALO $70.51
  • FRT $118.34
  • Technical
  • Relative Strength Index (RSI)
  • HALO 44.48
  • FRT 42.44
  • Support Level
  • HALO $52.43
  • FRT $94.62
  • Resistance Level
  • HALO $54.26
  • FRT $98.00
  • Average True Range (ATR)
  • HALO 3.42
  • FRT 1.77
  • MACD
  • HALO -0.49
  • FRT -0.30
  • Stochastic Oscillator
  • HALO 30.60
  • FRT 6.33

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 26.8 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

Share on Social Networks: